Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$4.07 - $10.6 $21.2 Million - $55.2 Million
-5,204,825 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$8.96 - $16.31 $26 Million - $47.4 Million
2,904,800 Added 126.29%
5,204,825 $52 Million
Q3 2021

Nov 15, 2021

BUY
$11.24 - $21.0 $1.27 Million - $2.37 Million
112,646 Added 5.15%
2,300,025 $44 Million
Q2 2021

Aug 16, 2021

BUY
$18.04 - $22.09 $14.3 Million - $17.5 Million
793,576 Added 56.94%
2,187,379 $70 Million
Q1 2021

May 14, 2021

BUY
$16.59 - $33.89 $3.79 Million - $7.74 Million
228,374 Added 19.6%
1,393,803 $42 Million
Q4 2020

Feb 02, 2021

BUY
$27.5 - $37.92 $291,032 - $401,307
10,583 Added 0.92%
1,165,429 $50.4 Million
Q3 2020

Nov 05, 2020

SELL
$34.44 - $43.75 $529,962 - $673,225
-15,388 Reduced 1.31%
1,154,846 $62.3 Million
Q2 2020

Jul 22, 2020

BUY
$27.12 - $45.97 $16 Million - $27.2 Million
591,303 Added 102.14%
1,170,234 $71.4 Million
Q1 2020

May 06, 2020

BUY
$26.16 - $63.5 $327,497 - $794,956
12,519 Added 2.21%
578,931 $26.6 Million
Q4 2019

Feb 03, 2020

BUY
$46.96 - $61.67 $6 Million - $7.88 Million
127,834 Added 29.15%
566,412 $49.7 Million
Q3 2019

Nov 04, 2019

SELL
$59.47 - $93.1 $24 Million - $37.6 Million
-403,543 Reduced 47.92%
438,578 $40.3 Million
Q2 2019

Jul 30, 2019

BUY
$75.84 - $105.21 $5.98 Million - $8.29 Million
78,813 Added 10.33%
842,121 $107 Million
Q1 2019

May 09, 2019

BUY
$64.44 - $104.11 $991,022 - $1.6 Million
15,379 Added 2.06%
763,308 $120 Million
Q4 2018

Feb 07, 2019

BUY
$59.1 - $93.26 $8.63 Million - $13.6 Million
146,046 Added 24.26%
747,929 $74.2 Million
Q3 2018

Oct 25, 2018

BUY
$88.86 - $117.49 $20.7 Million - $27.4 Million
233,175 Added 63.24%
601,883 $87.9 Million
Q2 2018

Aug 02, 2018

BUY
$99.64 - $127.59 $6.8 Million - $8.71 Million
68,258 Added 22.72%
368,708 $57.9 Million
Q1 2018

Apr 23, 2018

BUY
$105.8 - $150.94 $28.9 Million - $41.3 Million
273,579 Added 1018.12%
300,450 $51.3 Million
Q4 2017

Feb 08, 2018

SELL
$81.25 - $130.7 $501,475 - $806,680
-6,172 Reduced 18.68%
26,871 $4.79 Million
Q3 2017

Oct 24, 2017

BUY
$57.74 - $91.42 $1.91 Million - $3.02 Million
33,043
33,043 $4.54 Million

Others Institutions Holding BLUE

About bluebird bio, Inc.


  • Ticker BLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,121,800
  • Market Cap $28.5M
  • Description
  • bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...
More about BLUE
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.